欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0311/001
药品名称CANIGEN Pi/L
活性成分
    • leptospira interrogans serogroup canicola inactivated 0.0 %
    • leptospira interrogans serogroup icterohaemorragiae inactivated 0.0 %
    • parainfluenza Virus attenuated 0.0 %
剂型Lyophilisate and solvent for suspension for injection
上市许可持有人VIRBAC
参考成员国 - 产品名称France (FR)
CANIGEN PI/L LYOPHILISAT ET SUSPENSION POUR SUSPENSION INJECTABLE POUR CHIENS
互认成员国 - 产品名称
    • Cyprus (CY)
    • Germany (DE)
      Virbagen canis Pi/L
    • Denmark (DK)
    • Belgium (BE)
      Canigen Pi/L
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Canixin Pi/L
    • Austria (AT)
      Virbagen canis Pi/L Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Hunde
    • Spain (ES)
      CANIGEN PI/L
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
      Canigen Pi/L
    • Hungary (HU)
      Canigen Pi/L vakcina A.U.V.
    • Bulgaria (BG)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2017/01/25
最近更新日期2022/05/16
药物ATC编码
    • QI07AI08 live canine parainfluenza virus + inactivated leptospira
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase